Lineage Cell Therapeutics (LCTX) Cash & Equivalents (2010 - 2026)
Lineage Cell Therapeutics (LCTX) recorded Cash & Equivalents of $37.36 million in Q2 2026, down 11.6% from $42.27 million a year earlier but up 3.9% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics reported Cash & Equivalents of $40.79 million, down 10.9% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $45.79 million in FY2024 (+29.2%), $35.44 million in FY2023 (+212.1%), $11.36 million in FY2022 (-79.6%) and $55.74 million in FY2021 (+71.1%).
- Quarterly Cash & Equivalents has ranged from $11.36 million in Q4 2022 to $78.06 million in Q1 2022 over the past five years.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with growth averaging 8.5% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 212.1% in Q4 2023, against a decline of 80.2% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $35.94 million (Q1 2026), $40.79 million (Q4 2025) and $40.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Lineage Cell Therapeutics | 227.62 Mn | 26.02 Mn | - | 37.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.36 Mn |
| Mar 31, 2026 | 35.94 Mn |
| Dec 31, 2025 | 40.79 Mn |
| Sep 30, 2025 | 40.46 Mn |
| Jun 30, 2025 | 42.27 Mn |
| Mar 31, 2025 | 47.89 Mn |
| Dec 31, 2024 | 45.79 Mn |
| Sep 30, 2024 | 27.75 Mn |
| Jun 30, 2024 | 29.62 Mn |
| Mar 31, 2024 | 43.58 Mn |
| Dec 31, 2023 | 35.44 Mn |
| Sep 30, 2023 | 31.47 Mn |
| Jun 30, 2023 | 33.89 Mn |
| Mar 31, 2023 | 15.45 Mn |
| Dec 31, 2022 | 11.36 Mn |
| Sep 30, 2022 | 24.75 Mn |
| Jun 30, 2022 | 70.86 Mn |
| Mar 31, 2022 | 78.06 Mn |
| Dec 31, 2021 | 55.74 Mn |
| Sep 30, 2021 | 60.81 Mn |
API Access
Lineage Cell Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();